NRG Therapeutics’ £16 Million Series A Fundraising

Mills & Reeve advised NRG Therapeutics on the deal.The Stevenage-based life sciences company, founded in 2018, focuses on therapeutic approaches that will restore mitochondrial function and…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now